<div class="el__leafmedia el__leafmedia--sourced-paragraph">
<p class="zn-body__paragraph speakable" data-paragraph-id="paragraph_F89DFE1D-688F-3DDB-494D-FB8CFCD8280A" data-act-id="paragraph_0">Getting a second booster shot of the Pfizer/BioNTech Covid-19 vaccine doesn&#8217;t offer long-lived protection against the virus, but  a new study finds that&#8221; protection against severe illness did not wane for at least several weeks,&#8221; according to <a href="http://www.nejm.org/doi/full/10.1056/NEJMoa2201570" target="_blank" rel="noopener">CNN</a>.</p>
<p><span style="font-weight: 400;">The study, published this week in the New England Journal of Medicine, examines more than 1.25 million people in Israel 60 or older who have been fully vaccinated. The time period of the study was January through March 2022, when the Omicron variant of the virus became dominant.</span></p>
<p><span style="font-weight: 400;">“The rate of severe Covid-19 infection in the fourth week after a fourth dose of vaccine was lower than in people who got only three doses by a factor of 3.5,” CNN </span><a href="https://www.cnn.com/2022/04/05/health/israel-fourth-dose-study/index.html"><span style="font-weight: 400;">reported</span></a><span style="font-weight: 400;">. “However, protection against severe illness did not seem to wane in the six weeks after the fourth shot, though the study period wasn’t long enough to determine exactly how long this protection lasts.”</span></p>
<p><span style="font-weight: 400;">The researchers, though, did say there was some benefit from a fourth shot.</span></p>
<p><span style="font-weight: 400;">“Overall, these analyses provided evidence for the effectiveness of a fourth vaccine dose against severe illness caused by the omicron variant, as compared with a third dose administered more than 4 months earlier. For confirmed infection, a fourth dose appeared to provide only short-term protection and a modest absolute benefit,” they wrote.</span></p>
<p><span style="font-weight: 400;">“Several reports have indicated that the protection against hospital admission conferred by a third dose given more than 3 months earlier is substantially lower against the omicron variant than the protection of a fresh third dose against hospital admission for illness caused by the B.1.617.2 (delta) variant. In our study, a fourth dose appeared to increase the protection against severe illness relative to three doses that were administered more than 4 months earlier,” the researchers wrote.</span></p>
</div>
<div data-paragraph-id="paragraph_4CA65256-9163-6FE4-F433-FB8DC9B0505E" data-act-id="paragraph_1">
<p>The Israeli study comes after another that found a new anti-viral drug has been shown in early testing to eliminate COVID-19 infections in just a few days, the fastest so far identified.The drug, molnupiravir, &#8220;effectively neutralized infections of SARS-CoV-2 (the virus causing COVID) among a sample group by day three after starting therapy,&#8221; Study Finds <a href="https://www.studyfinds.org/molnupiravir-covid-3-days/">reported</a>. &#8220;Meanwhile, other COVID-19 patients taking a placebo took up to five days to make the same medical progress. For some patients in the control group, their recovery took even longer.&#8221;</p>
<p>&#8220;Molnupiravir is an oral antiviral prodrug that boasts broad activity against numerous coronaviruses. Prodrugs &#8216;switch on&#8217; and become active once they enter the body. Importantly, the drug is active against SARS-CoV-2 and its variants, including Delta and Omicron,&#8221; the website wrote.</p>
<p>The Food and Drug Administration (FDA) has already approved an emergency use authorization (EAU) request for molnupiravir, which is also in use in other countries, including Japan, Australia and Britain.</p>
<p>The findings came as part of what was called a “MOVe-OUT” trial, which was double blind and randomized, as well as being placebo-controlled. The researchers used PCR tests to measure the viral loads of SARS-CoV-2 in patients, then compared the results of using the drug versus those from patients given placebos.</p>
<p>“This analysis of the final virologic outcome data from MOVe-OUT confirms previous observations demonstrating that a 5-day treatment course of twice-daily 800 mg molnupiravir results in a more rapid decline in viral RNA and faster elimination of infectious virus than placebo,&#8221; Dr. Julie Strizki said in a media <a href="https://www.escmid.org/fileadmin/src/media/PDFs/2News_Discussions/Press_activities/2022/2022-03-31-ECCMID-01-New_virology.pdf">release</a>. &#8220;This study provides additional evidence that molnupiravir helps those infected clear SARS-CoV-2 faster than placebo, and supports MOVe-OUT’s primary finding that molnupiravir can lower the risk of progression to serious illness in this high-risk cohort.&#8221;</p>
</div>
<p><em>Joseph Curl has covered politics for 35 years, including 12 years as White House correspondent, and ran the Drudge Report from 2010 to 2015. Send tips to josephcurl@dailywire.com and follow him on Twitter @josephcurl.</em></p>
<div data-paragraph-id="paragraph_4CA65256-9163-6FE4-F433-FB8DC9B0505E" data-act-id="paragraph_1"></div>

<script async src="https://www.instagram.com/embed.js"></script>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
<script async src="https://www.tiktok.com/embed.js"></script><div data-widget-host="revcontent" data-pub-id="165152" data-widget-id="290588"></div><script src="https://delivery.revcontent.com/165152/290588/widget.js"></script>

Study Finds That Protection Against COVID-19 From 4th Shot Fades Quickly

CONTINUE READING

Vegas Family Claims Craft Crashed In Backyard, 9-Foot Aliens Emerged

Endless Pride: British Library Posts About Fish That Can Change Its Sex

Russia Taking Over Ukraine Not A ‘Top Foreign Policy Priority,’ GOP Presidential Candidate Says

America Has Spoken: There Are Two Genders. Period.

NY Times, WaPo Do Cartwheels To Spin Biden’s Clumsy Tumble; Twitterers Shred Them

Here’s The Weirdest Story You’ll Ever Read About Sen. Dianne Feinstein

News

COVID

COVID-19 Vaccine

A video goes viral showing a baby being refused his mother by two gay "dads". This is just the tip of the iceberg, which is why we will have an important discussion today about surrogacy. 

Hour 1

The Matt Walsh Show

Ep. 1765 - This Video Is One Of The Worst Things I've Seen In A Long Time 

The Strait of Hormuz officially opens for business (kind of), the Pope makes “shocking” comments on immigration, and President Trump promises UFO disclosure at TPUSA. 


The Michael Knowles Show

Ep. 1956 -  Pope Leo's "SHOCKING" Immigration Comments EXPLAINED

A false miscreed has corrupted our leadership class.


The Andrew Klavan Show

Ep. 1275 - Dumb, Dumber and Progressive

President Trump announces a 10-day ceasefire between Lebanon and Israel, a murder-suicide involving former Democratic Lieutenant Governor Justin Fairfax shakes Virginia, and France and Britain hold a conference to secure the Strait of Hormuz – after the Iranian conflict ends. Get the facts first with Morning Wire.

- - -

Ep. 2738

- - -

Wake up with new Morning Wire merch: https://bit.ly/4lIubt3

- - -

Today's Sponsors:

Alliance Defending Freedom - Visit https://JoinADF.com/WIRE or text 'WIRE' to 83848 to learn more.

Pocket Hose - Text MORNING to 64000 to get a FREE pocket pivot and their 10-pattern sprayer with the purchase of ANY size Copper Head hose. Message and data rates may apply.

Morning Wire

U.S. Expands Hormuz Blockade & VA Fairfax Deaths Investigated | 4.17.26

U.S. Expands Hormuz Blockade & VA Fairfax Deaths Investigated | 4.17.26 [Member Exclusive]

A ceasefire goes into effect between Israel and Lebanon, a tragic murder-suicide rocks Virginia, and Dairy Queen deploys AI in the drive-thru. Get the facts first with Evening Wire.
- - -
Ep. 2737
- - -
Wake up with new Morning Wire merch: https://bit.ly/4lIubt3 
- - -
Today’s Sponsor:

Alliance Defending Freedom - Visit https://JoinADF.com/WIRE or text “WIRE” to 83848 to learn more.


Menu

— News —

Study Finds That Protection Against COVID-19 From 4th Shot Fades Quickly